US

Jin-Chen Yu

This inventor holds 0 USPTO granted patents, plus 6 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin-Chen Yu. Retrieved from https://idiyas.com/inventor/jin-chen-yu-bpuf3u29

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Loading Chart...

Title: Jin-Chen Yu: Innovator in Neurofibroma Treatment

Introduction

Jin-Chen Yu is an inventor based in the United States, recognized for his contributions to the field of medical treatments, particularly in the local treatment of neurofibromas. His innovative approach focuses on a method that provides targeted therapy for neurofibromas, which are benign tumors that can cause discomfort and other complications.

Latest Patents

Jin-Chen Yu holds a patent for a method titled "Local Treatment of Neurofibromas." This patent describes a technique for treating various types of neurofibromas, including dermal, subdermal, and superficial plexiform neurofibromas. The method involves the local application of a composition to the neurofibroma, either topically or intralesionally. Importantly, this method does not include systemic administration of the composition, ensuring a focused treatment approach.

Career Highlights

Throughout his career, Jin-Chen Yu has worked with notable companies in the pharmaceutical sector, including Nexgenix Pharmaceuticals, Inc. His work has contributed to advancements in medical treatments, particularly in the area of dermatological conditions.

Collaborations

Jin-Chen Yu has collaborated with Ruihong Chen, a fellow professional in the field. Their partnership has likely fostered innovative ideas and developments in the treatment of neurofibromas.

Conclusion

Jin-Chen Yu's work in the local treatment of neurofibromas showcases his commitment to improving patient care through targeted therapies. His innovative methods and collaborations highlight the importance of focused research in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…